BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36519298)

  • 1. Cardiac Screening and Disease Characteristics of Patients with Ocular Sarcoidosis.
    Van Swol JM; Hawkins ET; Joseph ED; Nguyen SA; Anderson RJ; Thompson EB; Perry LJ; Sandhu HS
    Ocul Immunol Inflamm; 2024 Feb; 32(2):148-153. PubMed ID: 36519298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features and Course in Patients Diagnosed with Ocular Sarcoidosis without Previously Known Systemic Disease at a Tertiary Referral Center in Turkey.
    Kemer Atik B; Altan C; Yargı Özkoçak B; Basarir B
    Ocul Immunol Inflamm; 2024 Feb; 32(2):168-174. PubMed ID: 37756621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing Features of Ocular Sarcoidosis in an International Cohort of Uveitis Patients.
    Acharya NR; Browne EN; Rao N; Mochizuki M;
    Ophthalmology; 2018 Jan; 125(1):119-126. PubMed ID: 28823384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low utility of ocular screening in sarcoidosis in Finland.
    Joukainen E; Antonen J; Leinonen S
    Acta Ophthalmol; 2024 Jun; 102(4):435-440. PubMed ID: 37665138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular sarcoidosis prevalence and clinical features in the Northern Ireland population.
    Reid G; Williams M; Compton M; Silvestri G; McAvoy C
    Eye (Lond); 2022 Oct; 36(10):1918-1923. PubMed ID: 34556818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications.
    Han YS; Rivera-Grana E; Salek S; Rosenbaum JT
    JAMA Ophthalmol; 2018 Feb; 136(2):109-115. PubMed ID: 29327057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcoidosis: experience in a Mexican ophthalmological clinic.
    Salazar-Rodríguez JA; Sarmiento-Forero D; Hubbe-Tena C; Concha-Del-Rio LE
    BMC Ophthalmol; 2023 Jul; 23(1):330. PubMed ID: 37474932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of Serum microRNA in Diagnosed Ocular Sarcoidosis versus Idiopathic Uveitis with Ocular Manifestations of Sarcoidosis.
    Saito S; Keino H; Takasaki I; Abe S; Kohno H; Ichihara K; Hayashi I; Nakayama M; Tsuboshita Y; Miyoshi S; Okamoto S; Okada AA
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis.
    Evans M; Sharma O; LaBree L; Smith RE; Rao NA
    Ophthalmology; 2007 Feb; 114(2):325-33. PubMed ID: 17123620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of screening for uveitis in subjects with sarcoidosis.
    Koh LHL; Sims JL; Pepin F; Wilsher M; Niederer RL
    Respir Med; 2024 Apr; 224():107562. PubMed ID: 38342356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic categorization according to the First International Workshop on Ocular Sarcoidosis (FIWOS) criteria in a series of 11 patients.
    Meneses CF; Egües CA; Uriarte M; Errazquin N; Valero Jaimes A; Maíz O; Belzunegui J; Blanco A
    Reumatol Clin; 2017; 13(1):25-29. PubMed ID: 26948714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations and risk factors for poor visual outcomes of ocular sarcoidosis in Taiwan.
    Lai IW; Lin CP; Hsieh YT; Yeh PT
    J Formos Med Assoc; 2022 Aug; 121(8):1560-1566. PubMed ID: 35027256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ocular and neuro-ophthalmic manifestations of sarcoidosis: retrospective study of 30 cases].
    Bezo C; Majzoub S; Nochez Y; Leruez S; Charlin JF; Milea D; Pisella PJ
    J Fr Ophtalmol; 2013 Jun; 36(6):473-80. PubMed ID: 23545336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic advancements.
    Dammacco R; Biswas J; Kivelä TT; Zito FA; Leone P; Mavilio A; Sisto D; Alessio G; Dammacco F
    Int Ophthalmol; 2020 Dec; 40(12):3453-3467. PubMed ID: 32740881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Repository Corticotropin Gel for Ocular Sarcoidosis.
    Oh DJ; Singh A; Kanu LN; Lobo-Chan AM; MacIntosh PW; Bhat P
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1420-1424. PubMed ID: 33826473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Markers in Ocular Sarcoidosis in A High TB Endemic Population - A Multicentre Study.
    Babu K; Biswas J; Agarwal M; Mahendradas P; Bansal R; Rathinam SR; Basu S; Ganesh SK; Konana VK; Vedhanayaki R; Philips M; Choudhary T
    Ocul Immunol Inflamm; 2022 Jan; 30(1):163-167. PubMed ID: 32870050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and management of ocular sarcoidosis.
    Takase H
    Immunol Med; 2022 Mar; 45(1):12-21. PubMed ID: 34214013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related differences in the clinical features of ocular sarcoidosis.
    Takayama K; Harimoto K; Sato T; Sakurai Y; Taguchi M; Kanda T; Takeuchi M
    PLoS One; 2018; 13(8):e0202585. PubMed ID: 30138345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of IWOS Suggestive Ocular Signs in Slovenian Uveitis Patients with Confirmed Pulmonary Sarcoidosis.
    Fakin A; Terčelj M; Vidović Valentinčič N
    Ocul Immunol Inflamm; 2016 Dec; 24(6):660-664. PubMed ID: 26645946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the diagnosis of ocular sarcoidosis.
    O'Keefe GAD; Rao NA
    Indian J Ophthalmol; 2022 Apr; 70(4):1121-1129. PubMed ID: 35325997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.